Dale Joshua L, Sayeed Zain
Osteopathic Medicine, William Carey University College of Osteopathic Medicine, Hattiesburg, USA.
Orthopedics, Doctors Hospital at Renaissance, Edinburg, USA.
Cureus. 2025 Mar 31;17(3):e81543. doi: 10.7759/cureus.81543. eCollection 2025 Mar.
Glucocorticoid therapy is a well-established iatrogenic cause of secondary osteoporosis. This form of osteoporosis is known as glucocorticoid-induced osteoporosis (GIOP). We present the case of a 78-year-old woman who developed avascular necrosis and complete collapse of the femoral head after a high-dose steroid taper for asthma. Imaging showed subsequent femoral head collapse with the presence of protrusio acetabuli. The patient underwent a posterior total hip arthroplasty. This case is unique because of the extremely high dose of steroids and the timing of her fracture. The case reveals the adverse effects of prolonged glucocorticoid use on bone health, showing the need for proper preventive measures such as bone density scans and proper supplementation if needed. Using anti-osteoporotic medications such as bisphosphonates or denosumab can mitigate the occurrence of GIOP. Early recognition and proper management are critical in decreasing the incidence of GIOP-related fractures.
糖皮质激素治疗是继发性骨质疏松症公认的医源性病因。这种形式的骨质疏松症被称为糖皮质激素性骨质疏松症(GIOP)。我们报告一例78岁女性病例,该患者因哮喘接受大剂量糖皮质激素减量治疗后发生股骨头缺血性坏死并完全塌陷。影像学检查显示随后出现股骨头塌陷并伴有髋臼内陷。患者接受了后路全髋关节置换术。该病例独特之处在于使用的糖皮质激素剂量极高以及骨折发生的时间。该病例揭示了长期使用糖皮质激素对骨骼健康的不良影响,表明需要采取适当的预防措施,如进行骨密度扫描,并在必要时进行适当补充。使用双膦酸盐或地诺单抗等抗骨质疏松药物可以减轻GIOP的发生。早期识别和妥善管理对于降低GIOP相关骨折的发生率至关重要。